Efficacité clinique du 2L®ALERG, un nouveau traitement de type immunomodulateur par voie sublinguale dans le rhume des foins : une étude en double insu contre placebo
Authors:
- X. Van der BremptXBX. Van der Brempt
- J. CumpsJCJ. Cumps
- E. CapieauxECE. Capieaux
- 1 June 2011
- journal article
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 51 (4) , 430-436
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Towards evidence‐based medicine in specific grass pollen immunotherapyAllergy, 2010
- Allergen immunotherapyJournal of Allergy and Clinical Immunology, 2010
- Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyAllergy, 2008
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*Allergy, 2008
- Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trialsAllergy, 2007
- Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitisJournal of Allergy and Clinical Immunology, 2004
- The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?Immunology, 2004